CADENCE PHARMACEUTICALS INC R3 - 12738T100
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q4 2013
· Q1 2013
Value (USD)
Total reported value ($000)
$407.5M
QoQ value delta ($000)
+$405.2M
(+17570.25%)
Implied price effect (QoQ)
+19.4%
Shares
Total shares
50,992,875
QoQ shares delta
+50,648,311
(+14699.25%)
Total shares held by funds (by quarter)
Top holders (Q4 2013)
Top 25 only
Full list
Early Q1 2014 data: only 3 institutional holders reported so far. More will appear as funds file with the SEC.